Seeking Alpha

The U.S. gives a two-year, $4.7M contract to Cytori Therapeutics (CYTX) for a stem cell therapy...

The U.S. gives a two-year, $4.7M contract to Cytori Therapeutics (CYTX) for a stem cell therapy to treat "burns caused by thermal or radioactive bombs." With key milestones, the deal could be worth $106M over five years, the company (with $10M in annual revenue) reports. CYTX +17.1% premarket.
Comments (5)
  • bull_market_somewhere
    , contributor
    Comments (113) | Send Message
     
    ah yes, war on the horizon.
    28 Sep 2012, 10:10 AM Reply Like
  • Papaswamp
    , contributor
    Comments (2178) | Send Message
     
    That's a bit worrisome....
    28 Sep 2012, 11:18 AM Reply Like
  • bull_market_somewhere
    , contributor
    Comments (113) | Send Message
     
    hey, gotta manufacture your way out of this economic malaise somehow!
    28 Sep 2012, 12:49 PM Reply Like
  • orangutan
    , contributor
    Comments (215) | Send Message
     
    Why should it matter how the burns were caused?
    28 Sep 2012, 01:50 PM Reply Like
  • bull_market_somewhere
    , contributor
    Comments (113) | Send Message
     
    because the treatment is specialized for battle wounds, not boo boos. there is a war on the horizon, and america is hedging their position.
    28 Sep 2012, 01:53 PM Reply Like
DJIA (DIA) S&P 500 (SPY)